Clinical Trials in Arizona

Showing 10321-10340 of 14,395 trials

Molecular Regulation of Muscle Glucose Metabolism

NCT01581736

This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.

ObesityType 2 Diabetes Mellitus

Mayo Clinic48 participantsStarted Apr 2012

Scottsdale, Arizona, United States

COMPLETEDPhase 231 miles

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

NCT02197130

This study is a 26 week, randomized, parallel group, double blind comparison of PF-02545920 5 mg, PF-02545920 20 mg, and placebo dosed BID in the treatment of motor impairment of subjects with Huntington's Disease. A total of approximately 260 subjects are planned to be randomized in the study. Primary endpoint is the change from baseline in the Total Motor Score (TMS) assessment of the Unified Huntington Disease Rating Scale (UHDRS) after 26 weeks of treatment. secondary endpoints will include change from baseline in the Total Maximum Chorea (TMC) score of the UHDRS after 13 and 26 weeks of treatment and Clinical Global Impression-Improvement score after 13 and 26 weeks of treatment.

Huntington's Disease

Pfizer272 participantsStarted Sep 2014

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +54 more locations

Molecular Regulation of Muscle Glucose Metabolism

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Find Trials by Condition in Arizona

Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

ITU Treatment for Chronic Epicondylitis Musculoskeletal Pain Reduction

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Peri-orbital and Peri-oral Wrinkle Reduction Trial

Safety Escalating Repeat IV, in Stroke Patients

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Clinical Evaluation of Patients With X-linked Retinoschisis